103 related articles for article (PubMed ID: 523002)
1. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
Cortinovis A; Paolini FA; Crippa A
Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002
[No Abstract] [Full Text] [Related]
2. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
Cortinovis A; Paolini FA; Crippa A
Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of acute and chronic liver disease as well as several malabsorption syndromes with 2 mercaptopropionylglycine MPG (thiola) (author's transl)].
Markoff NG
Schweiz Rundsch Med Prax; 1975 Jul; 64(30):958-61. PubMed ID: 1144310
[No Abstract] [Full Text] [Related]
4. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine].
Marinai E; Ulivieri P; Righi A
Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
[TBL] [Abstract][Full Text] [Related]
6. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
Calabrese L; Zoni R
Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
[No Abstract] [Full Text] [Related]
7. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
Surrenti C; Arcangeli A; Casini A
Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Thiola in post-hepatitis hepatic insufficiency].
Precchia G; d'Amico A; Precchia E; Precchia A; Vela R
Minerva Med; 1977 Jul; 68(36):2505-7. PubMed ID: 887229
[No Abstract] [Full Text] [Related]
9. [New therapeutic prospects in lead poisoning: alpha-mercaptopropionylglycine].
Franco G; Malamani T; Scalisi L
Minerva Med; 1979 Sep; 70(41):2811-9. PubMed ID: 492550
[TBL] [Abstract][Full Text] [Related]
10. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies].
Dioguardi N; Ideo G; De Franchis R; Ronchi G
Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical and clinical studies on the influence of 2-mercaptopropionylglycine on liver cell function (author's transl)].
Zimmer G; Ohlenschläger G; Berger J
Arzneimittelforschung; 1978; 28(6):961-70. PubMed ID: 219869
[TBL] [Abstract][Full Text] [Related]
12. 2-mercaptopropionylglycine in the treatment of the hyperviscosity syndrome.
Triolo L; Magris D; Mian G
Haematologica; 1980 Feb; 65(1):135. PubMed ID: 6768650
[No Abstract] [Full Text] [Related]
13. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro].
Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF
Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410
[TBL] [Abstract][Full Text] [Related]
14. [Long-term therapy of rheumatoid arthritis with alpha-mercaptopropionylglycine].
Carrozzini B; Selvaggio G
Minerva Med; 1982 May; 73(19):1301-4. PubMed ID: 6804890
[No Abstract] [Full Text] [Related]
15. [Prevention of cysteine calculosis by the continuous administration of alpha-mercaptopropionylglycine].
Berio A
Minerva Pediatr; 1983 Dec; 35(23-24):1197-1206. PubMed ID: 6425620
[No Abstract] [Full Text] [Related]
16. [The action of thiopronine in the treatment of chronic recurrent pancreatitis. Double-blind study of 105 patients].
Valente U; Campisi C; Barabino C; De Rosa E; Traverso C; Pozzati A; Fontana I
Minerva Chir; 1983 Apr; 38(8):573-6. PubMed ID: 6346137
[No Abstract] [Full Text] [Related]
17. [Alpha-mercaptopropionylglycine (Thiola) in the treatment of chronic liver diseases with special reference to the effects of the drug on the index of prognosis in alcoholic cirrhosis].
Mantero O; Conti F; Bertoli L
Minerva Med; 1974 Feb; 65(9):460-7. PubMed ID: 4820725
[No Abstract] [Full Text] [Related]
18. Chemical protection of mice against radiation induced sickness and mortality by 2-mercaptopropionylglycine.
Kumar A; Uma Devi P
Radiobiol Radiother (Berl); 1983; 24(2):231-4. PubMed ID: 6867303
[No Abstract] [Full Text] [Related]
19. Radioprotective effect of 2-mercaptopropionylglycine on the small intestine of Swiss albino mice.
Devi PU; Saini MR; Verma A; Saharan BR
Indian J Exp Biol; 1977 Jan; 16(1):86-8. PubMed ID: 615131
[No Abstract] [Full Text] [Related]
20. Radioresponse of peripheral blood and its modification by MPG (2-mercaptopropionylglycine) in mice III leucocyte.
Kumar S; Uma Devi P
Radiobiol Radiother (Berl); 1983; 24(1):31-4. PubMed ID: 6856796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
